Navigation Links
Kentucky's PSE Blocking Technology Leading To Progress In Battle Against Meth
Date:10/31/2012

LUTHERVILLE, Md., Oct. 31, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today released the latest results achieved by the real-time, stop-sale system in Kentucky.  Data aggregated through the National Precursor Log Exchange (NPLEx) for the first three quarters of 2012 shows electronic technology in the Bluegrass State blocked the sale of more than 24,000 boxes of medicines containing pseudoephedrine (PSE) preventing more than 62,000 grams from potentially being diverted by meth criminals.

"While the Commonwealth of Kentucky continues to wage a long battle against methamphetamine cooks and dealers, retailers around the state are seeing results using real-time, stop-sale technology that blocks unlawful attempted purchases of products containing pseudoephedrine," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "With thousands of blocks each month, Kentucky law enforcement officials can access valuable criminal data in real time. Officers can receive alerts when a suspect has exceeded his pseudoephedrine purchasing limits or when a pharmacy makes an abnormal number of sales in a given time period. By targeting criminals, NPLEx ensures that responsible Kentuckians will continue to have access to the cold and medicines of their choice."

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion.  NADDI also sponsors and conducts specialized educational seminars and conferences.


'/>"/>
SOURCE National Association of Drug Diversion Investigators
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
2. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
3. Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
4. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
5. Medical Virtual Reality Technology Nominated Twice in the 2012 Accenture Innovation Awards
6. DICOM Grid Collaborates with Mayo Clinic on Mobile Image Viewing Technology
7. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
8. Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
9. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
10. Caliber IDs VivaScope technology found to be 100% sensitive for basal cell carcinoma diagnosis
11. Pomona Valley Hospital is First in the Region to Use Innovative Technology for Neonates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... , ... SuperCloset is proud to officially launch our “Helping Veterans Grow ... and obstacles veterans’ need to overcome in order to face their life changes upon ... veteran(s) with a donated SuperCloset product based on the needs and ability of helping ...
(Date:5/27/2016)... ... ... More than a third of American adults are considered obese, says the ... increased attention in recent years, as an article published May 18th on ... people are familiar with the basic requirements of maintaining a healthy diet and exercise ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... health care world, this installment is bolstered by inspiring human interest stories, courtesy ... to the developing trends and tech within the industry, from leading advocates and ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
Breaking Medicine News(10 mins):